~~<i id='56C7CF6634'><strike id='56C7CF6634'><tt id='56C7CF6634'><pre id='56C7CF6634'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：Wikipedia 2025-09-06 04:51:26 - browse：5

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： FDA approves Sage Therapeutics’ rapid

Wikipedia

hotspot

knowledge

hotspot

GodofredoA.Vásquez/APReluctanceamongdairyfarmerstoreportH5N1birdfluoutbreakswithintheirherdsorallowt

WSS

Use wet bulb globe temperature, not heat index, to protect workers

FDA scientists endorse Pfizer/BioNTech Covid

Steward Health Care files for bankruptcy

Telehealth startups turn to complex chronic diseases

Medicare slashes safety net hospital payments by nearly $1 billion

How to ethically and practically extend health care to all

hotspot

explore

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

H.R. 3 is the wrong path to lower drug costs

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech startup Celsius cuts 75% of staff ahead of first trial start

In age of alternative facts, a scholarly course on calling out crap

H5N1 bird flu: what we're starting to learn about infection in cows

Duchenne breakthrough therapy leaves behind pioneering families

After gene therapy, two congenitally deaf children hear for the first time

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: What to know about H5N1 bird flu

hotspot

Elevance, private equity launch primary care company

Software glitch causes Tandem insulin pump to shutdown, FDA warns

CDC wastewater surveillance dashboard to track bird flu hotspots

Software glitch causes Tandem insulin pump to shutdown, FDA warns

How to ethically and practically extend health care to all

Elevance, private equity launch primary care company

hotspot

knowledge

hotspot

hotspot